MAP1LC3A and prostate cancer: Notably, we found that autophagy was significantly activated along with an increased LC3 II/I ratio and degradation of p62 after metformin treatment in cervical cancer (HeLa), prostate cancer (PC‐3) and breast cancer (MDA‐MB‐231) cells (Figure S4), which is in accordance with other studies.